Hennion & Walsh Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181K Buy
13,736
+3,377
+33% +$75.4K 0.01% 936
2026
Q1
$272K Buy
10,359
+2,197
+27% +$276K 0.01% 848
2025
Q4
$2.02M Buy
+8,162
New +$1.86M 0.07% 346

Other funds holding GOSS

Hennion & Walsh Asset Management's GOSS Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Gossamer Bio (GOSS) stake by 33% in Q2 2026, buying an estimated $75.4K and bringing the position to 13,736 shares worth $181K. The position accounts for 0.01% of the portfolio, ranked #936.

Hennion & Walsh Asset Management first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.02M in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Hennion & Walsh Asset Management held 13,736 shares of Gossamer Bio worth $181K as of Q2 2026.
  • Hennion & Walsh Asset Management bought 3,377 Gossamer Bio shares in Q2 2026, an estimated $75.4K.
  • Gossamer Bio made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #936 holding.
  • Hennion & Walsh Asset Management first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Hennion & Walsh Asset Management's Gossamer Bio position peaked at $2.02M in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.